Sean O'Brien

Sean O'Brien Email and Phone Number

Co-founder and CEO @ Sisu Pharma
San Diego, CA, US
Sean O'Brien's Location
San Diego, California, United States, United States
Sean O'Brien's Contact Details

Sean O'Brien personal email

n/a
About Sean O'Brien

Biotech executive with significant success in growing early stage and start-up value through program design and management underpinned by relationship building. A logical and skilled problem-solver who has hands on experience in influencing cross-functional teams to achieve corporate milestones. Key strengths are corporate strategy and management, driving consensus and building, negotiating and successfully managing alliances.Areas of Expertise: •Scientific Program Management • Translational Sciences • Strategy Implementation • Drug Discovery and Development •Business Development • Virtual Pharma • Intellectual Property •Contract Negotiation •Legal Review • CRO and Vendor Management • Scientific Collaborations •Due Diligence

Sean O'Brien's Current Company Details
Sisu Pharma

Sisu Pharma

View
Co-founder and CEO
San Diego, CA, US
Website:
sisupharma.com
Employees:
2
Sean O'Brien Work Experience Details
  • Sisu Pharma
    Co-Founder And Ceo
    Sisu Pharma
    San Diego, Ca, Us
  • Sisu Pharma
    Cofounder And Ceo
    Sisu Pharma May 2019 - Present
    San Diego, California, Us
    Targeting Cellular Stress to Treat Cancer and Neurodegenerative Disease
  • Endless Frontier Labs
    Founder At Endless Frontier Labs
    Endless Frontier Labs Sep 2022 - Jun 2023
    New York, Ny, Us
    Endless Frontier Labs (EFL) is a New York-based mentorship program supporting promising startups across the globe by helping them grow their business, scale their teams, and advance human welfare through science and technology based-entrepreneurship. Startup founders work with EFL’s network of investors, scientists, and industry experts with support from NYU Stern MBA consultants to maximize the potential for growth.
  • Chaperone Therapeutics, Inc.
    Vp Translational Sciences
    Chaperone Therapeutics, Inc. Feb 2019 - Jun 2021
    Chaperone develops breakthrough therapies for disorders of protein misfolding
  • G4 Oncology
    Co-Founder And Ceo
    G4 Oncology Jan 2018 - Dec 2019
    Small molecule oncology company targeting regulatory DNA motifs
  • Trilogy Therapeutics
    Co-Founder And Vp, Scientific And Corporate Affairs
    Trilogy Therapeutics Sep 2015 - Jan 2017
    Established business opportunity and strategy, business plan and co-founded companyRecruited KOLs to Advisory BoardScientific program review – identified areas required for value creation and established a plan to create complete partnering package post Phase I proof-of-conceptCoordinated compound supply chain to CMODesign and execution of in vivo proof-of-concept studies coordinating multiple CROsNegotiated Material Transfer Agreements, Memorandums of Understanding, Confidential Disclosure Agreements, Consulting Agreements, Master Service Agreements
  • Senhwa Biosciences
    Vp, Corporate Development
    Senhwa Biosciences May 2013 - Sep 2015
    San Diego, California, Us
    Integral part of team that took two non-clinical compounds with inactive programs into Phase I and Phase II studies, propelling the company to public listing and a $300MM valuation from $35MM investment in 18 monthsSet strategy - conceptualized and designed Phase II cancer study. Oversaw establishment of multicenter US/Korea/Taiwan trial with high caliber institutions in all countriesTook preclinical compound through toxicology studies to IND filing, including FDA interactions, toxicology studies and Clinical Protocol developmentInstigated and delivered $103MM + equity Licensing deal for a preclinical oncology program Negotiated and finalized Clinical Trial Agreements with 8 different institutions in 2014Developed partnerships with academic institutions - $9MM SU2C grant wonInstigated and oversaw Out-Licensing activities with small, medium and large pharma
  • Cylene Pharmaceuticals
    Vp, Research And Business Development
    Cylene Pharmaceuticals Oct 2011 - Apr 2013
    Identified opportunity, negotiated and closed deal for acquisition of lead oncology programs Out-Licensed Cylene’s Phase II DNA-quadruplex interacting oncology programFiled IND with FDA: Planned and executed development from pre-IND to phase IIManaged regulatory and technical transfer for early phase clinical trials Oversaw R&D process for preclinical programsInstigated numerous BD conversations. Dealt with Term Sheets, diligence materials and financing discussionsManagement of all corporate legal negotiations and transactionsOversight of Corporate Diligence proceedings
  • Cylene Pharmaceuticals
    Director Of Research And Business Development
    Cylene Pharmaceuticals Feb 2009 - Oct 2011
    Seek to identify and develop partnering and licensing opportunities in oncology. Influence current and future R&D efforts and focus them on maximizing their short and long-term value. Ensure that the Company’s direction and promotional activities are all supported by strong, well validated science.
  • Cylene Pharmaceuticals
    Director Drug Discovery Technologies & Project Management
    Cylene Pharmaceuticals Jul 2007 - Dec 2008
    IND filing – coordinating cross-disciplinary teamsManagement of ADME-PK and IT departmentsKey member of anticancer technology platform development team
  • Cylene Pharmaceuticals
    Computational Scientist
    Cylene Pharmaceuticals Aug 2005 - Jul 2007
  • Pfizer
    Computational Chemist
    Pfizer Sep 2002 - Oct 2004
    New York, New York, Us
  • Accelrys
    Computational Chemist
    Accelrys Oct 2002 - Sep 2004
    San Diego, Ca, Us
  • University Of Nottingham
    Computational Chemist
    University Of Nottingham Nov 2000 - Oct 2002
    Nottingham, Gb

Sean O'Brien Skills

Drug Discovery Drug Development Biotechnology Oncology Lifesciences R&d Life Sciences Medicinal Chemistry Biomarkers Pharmaceutical Industry Clinical Development Chemistry Bioinformatics Cancer Cheminformatics Computational Chemistry Business Development Biopharmaceuticals Technology Transfer Drug Design Cell Biology Informatics Project Management Immunology Cell Commercialization Pharmacokinetics Ind Molecular Modeling Drug Delivery Cro Research And Development Genomics Cell Culture Lc Ms In Vitro Assay Development Translational Medicine Neuroscience Purification Pharmaceuticals Corporate Strategy Formulation Corporate Development Strategic Alliances U.s. Food And Drug Administration

Sean O'Brien Education Details

  • The University Of Manchester
    The University Of Manchester
    Quantum Chemistry
  • The University Of Manchester
    The University Of Manchester
    Chemistry With French

Frequently Asked Questions about Sean O'Brien

What company does Sean O'Brien work for?

Sean O'Brien works for Sisu Pharma

What is Sean O'Brien's role at the current company?

Sean O'Brien's current role is Co-founder and CEO.

What is Sean O'Brien's email address?

Sean O'Brien's email address is dr****@****o.co.uk

What schools did Sean O'Brien attend?

Sean O'Brien attended The University Of Manchester, The University Of Manchester.

What are some of Sean O'Brien's interests?

Sean O'Brien has interest in Science And Technology, Economic Empowerment.

What skills is Sean O'Brien known for?

Sean O'Brien has skills like Drug Discovery, Drug Development, Biotechnology, Oncology, Lifesciences, R&d, Life Sciences, Medicinal Chemistry, Biomarkers, Pharmaceutical Industry, Clinical Development, Chemistry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.